GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Staar Surgical Co (FRA:SR3) » Definitions » Total Liabilities

Staar Surgical Co (FRA:SR3) Total Liabilities : €91.8 Mil (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Staar Surgical Co Total Liabilities?

Staar Surgical Co's Total Liabilities for the quarter that ended in Mar. 2024 was €91.8 Mil.

Staar Surgical Co's quarterly Total Liabilities increased from Sep. 2023 (€87.07 Mil) to Dec. 2023 (€94.21 Mil) but then declined from Dec. 2023 (€94.21 Mil) to Mar. 2024 (€91.77 Mil).

Staar Surgical Co's annual Total Liabilities increased from Dec. 2021 (€77.19 Mil) to Dec. 2022 (€78.07 Mil) and increased from Dec. 2022 (€78.07 Mil) to Dec. 2023 (€94.21 Mil).


Staar Surgical Co Total Liabilities Historical Data

The historical data trend for Staar Surgical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Staar Surgical Co Total Liabilities Chart

Staar Surgical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.88 49.48 77.19 78.07 94.21

Staar Surgical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.70 80.26 87.07 94.21 91.77

Staar Surgical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Staar Surgical Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=59.638+(28.855+0.095000000000001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0.988+4.635)
=94.2

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=448.131-353.92
=94.2

Staar Surgical Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=57.66+(28.636+0.088000000000001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0.988+4.395)
=91.8

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=453.132-361.365
=91.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Staar Surgical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Staar Surgical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Staar Surgical Co (FRA:SR3) Business Description

Traded in Other Exchanges
Address
25651 Atlantic Ocean Drive, Lake Forest, CA, USA, 92630
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also make lenses which are used in surgery that treats cataracts. The company offers products are ICLs used in refractive surgery and IOLs used in cataract surgery. The company generated sales are from the ophthalmic surgical product segment.

Staar Surgical Co (FRA:SR3) Headlines

No Headlines